Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment (Q38615808)

4 September 2017

Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment (English)

1 reference

4 September 2017

1 reference

2

Jerry Palmer

1 reference

4 September 2017

R David Leslie

1

1 reference

4 September 2017

Nanette C Schloot

series ordinal

3

1 reference

4 September 2017

Ake Lernmark

series ordinal

4

1 reference

4 September 2017

24 October 2015

1 reference

4 September 2017

1 reference

4 September 2017

59

1 reference

4 September 2017

1

1 reference

4 September 2017

13-20

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-015-3789-z

4 September 2017

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

The many faces of diabetes: a disease with increasing heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

Genetic cause of hyperglycaemia and response to treatment in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

Metabolic syndrome and autoimmune diabetes: action LADA 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

Obesity, islet cell autoimmunity, and cardiovascular risk factors in youth at onset of type 1 autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

Distinct monocyte gene-expression profiles in autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

Improved T cell assay for identification of type 1 diabetes patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

Identification of autoantibody-negative autoimmune type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

T-cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe beta-cell lesions in phenotypic type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

Impact of C-peptide preservation on metabolic and clinical outcomes in the Diabetes Control and Complications Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

Genetic analysis of adult-onset autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

Cord blood insulinoma-associated protein 2 autoantibodies are associated with increased risk of type 1 diabetes in the population-based Diabetes Prediction in Skåne study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

Clinical evolution of beta cell function in youth with diabetes: the SEARCH for Diabetes in Youth study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall II cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

The latest pharmacotherapy options for type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

Interventions for latent autoimmune diabetes (LADA) in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

Dipeptidyl peptidase 4 inhibitor sitagliptin maintains β-cell function in patients with recent-onset latent autoimmune diabetes in adults: one year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

Worse glycaemic control in LADA patients than in those with type 2 diabetes, despite a longer time on insulin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

Levels of C-peptide, body mass index and age, and their usefulness in classification of diabetes in relation to autoimmunity, in adults with newly diagnosed diabetes in Kronoberg, Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

Insulin therapy in people with type 2 diabetes: opportunities and challenges?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

Latent autoimmune diabetes of the adult: current knowledge and uncertainty

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: a nationwide, multicenter prospective study (LADA China Study 3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

Family history of type 2 diabetes is associated with decreased insulin sensitivity and an impaired balance between insulin sensitivity and insulin secretion in white youth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

Pharmacogenetics in type 2 diabetes: potential implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3789-Z

β-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment

21 January 2018

1 reference

12 December 2020

Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes

1 reference

12 December 2020

Association of T-cell reactivity with beta-cell function in recent onset type 1 diabetes patients

1 reference

12 December 2020

Accuracy and predictive value of classification schemes for ketosis-prone diabetes

1 reference

12 December 2020

Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4

1 reference

12 December 2020

Time to Insulin Initiation Cannot Be Used in Defining Latent Autoimmune Diabetes in Adults

1 reference

12 December 2020

LADA and CARDS: A Prospective Study of Clinical Outcome in Established Adult-Onset Autoimmune Diabetes

1 reference

12 December 2020

Markers of β-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 Diabetes

1 reference

12 December 2020

10.1007/S00125-015-3789-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

4 September 2017

0 references

1 reference